C

Cyclerion Therapeutics
D

CYCN

2.37000
USD
0.04
(1.72%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
8,439,433
أصول ذات صلة
ALNY
ALNY
6.65
(1.50%)
449.19 USD
AMGN
AMGN
6.28
(2.16%)
296.49 USD
A
ARWR
1.730
(9.21%)
20.510 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
GSK
GSK
0.105
(0.27%)
39.325 USD
LLY
LLY
16.80
(2.45%)
701.25 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
NVS
NVS
2.080
(1.70%)
124.210 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
R
RCKT
0.01500
(0.50%)
3.04500 USD
المزيد
الأخبار المقالات

العنوان: Cyclerion Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.